ArticleJCI insight2022
The TBK1/IKKε inhibitor amlexanox improves dyslipidemia and prevents atherosclerosis.
Peng Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this paperpooled itcites it
ArticleJCI insight2022
Peng Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.